SOCS2 is dispensable for BCR/ABL1-induced chronic myeloid leukemia-like disease and for normal hematopoietic stem cell function

por Hansen, N, Ågerstam, H, Wahlestedt, M, Landberg, N, Askmyr, M, Ehinger, M, Rissler, M, Lilljebjörn, H, Johnels, P, Ishiko, J, Melo, J V, Alexander, W S, Bryder, D, Järås, M, Fioretos, T
Publicado 2013